Genetic alteration of SJ293TS cells and modification of serum-free media enhances lentiviral vector production

Successful cell and gene therapy clinical trials have resulted in the US Food and Drug Administration and European Medicines Agency approving their use for treatment of patients with certain types of cancers and monogenetic diseases. These novel therapies, which rely heavily on lentiviral vectors to...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Matthew Bauler, Francesca Ferrara, Brandon Lowe, Jordan A. Beard, Chris Wincek, Matthew M. Wielgosz, Jeoungeun J. Park, Na Shang, Saikat Nandy, Cai Li, Deanna M. Langfitt, Sheng Zhou, Robert E. Throm
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2024-06-01
coleção:	Molecular Therapy: Methods & Clinical Development
Assuntos:	lentivirus vectors GMP manufacturing lentiviral vectors clinical gene therapy cell therapy gene therapy
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S232905012400086X
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!